NOW AVAILABLE: New Integrated Test Result (i31-ROR) for Precise and Personalized Risk of Recurrence Prediction. LEARN MORE


Melanoma Prognosis

Staging-only approach misses patients with aggressive tumor biology

DecisionDx®-Melanoma Overview

Genomic testing more accurately predicts individual risk of recurrence or metastasis

Clinical Evidence

DecisionDx-Melanoma is extensively researched including multiple prospective studies

Test Process

Learn more about the straightforward ordering process for DecisionDx-Melanoma

Melanoma Expert Video Series

Expert opinions on the treatment and ongoing management of cutaneous melanoma

On-Demand Educational Programs

Access to virtual educational programs on the management of melanoma and other dermatalogic cancers

Scientific References

DecisionDx-Melanoma is supported by more than 25 peer-reviewed publications

Additional Cutaneous Melanoma Tests

Additional DecisionDx tests designed to improve the treatment and management of melanoma​

Scroll to Top